CuraCell TX AB
559280-8546ActiveEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Oversigt
- 5
- Medarbejdere
- 45t SEK
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Thomas Jaecklin
Board Member
+6 flere kontakter i Funnelfeedr
Beskrivelse
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559280854601
Beslutningstagere
10 kontakter i FunnelfeedrHåkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Thomas Jaecklin
Board Member
Jonas Båtelson
CEO & Co-founder
Martin Forster
Board Member
Martina Ochel
COO
Per-Henrik Holmqvist
Head of CMC
Torbjörn Ström
Head of Clinical Operations
Andre kontakter
Agnes Asp Sandin
Data Protection Officer
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrUltimovacs AB
0 medarbejderePioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Anocca AB
100–199 medarbejdereEngineering precision T-cell immunotherapies for hard-to-treat cancers.
SeqCure Immunology AB
1 medarbejdereDeveloping personalized, non-genetically engineered cell therapy for advanced cancer.
ZELLUNA ASA
7 medarbejderePioneering TCR-NK cell therapies to eliminate solid cancers effectively.
ZELLUNA IMMUNOTHERAPY AS
9 medarbejderePioneering TCR-NK cell therapies to eliminate solid cancers safely.
Udforsk mere
Spørgsmål om CuraCell TX AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo